HALO

Halozyme Therapeutics, Inc. News Headlines

$9.48
*  
0.05
0.53%
Get HALO Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog
8/14/2014 10:53:00 AM - Zacks.com

Halozyme Therapeutics Q2 Loss Narrows, Results Beat View
8/11/2014 9:27:00 PM - RTT News

Halozyme Therapeutics Q2 Loss Narrows - Quick Facts
8/11/2014 5:13:00 PM - RTT News

Earnings Reaction History: Halozyme Therapeutics Inc., 33.3% Follow-Through Indicator, 15.0% Sensitive
8/11/2014 11:51:56 AM - MT Newswires

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha

U.S. Hot Stocks: Hot Stocks to Watch
7/11/2014 9:11:00 AM - Dow Jones Business News

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts - Part 2
6/25/2014 9:09:00 AM - Seeking Alpha

Halozyme To Present At JMP Securities Conference; Webcast At 2:30 PM ET
6/24/2014 1:30:00 PM - RTT News

Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Analyst Blog
6/11/2014 12:16:00 PM - Zacks.com

Halozyme Study Clinical Hold Lifted by FDA - Analyst Blog
6/5/2014 6:26:00 PM - Zacks.com

Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results
6/5/2014 2:52:41 PM - Benzinga

Thursday's ETF Movers: XBI, EWD
6/5/2014 2:11:53 PM - BNK Invest

Halozyme Therapeutics To Present At Jefferies Conference; Webcast At 12:30 PM ET
6/5/2014 11:31:00 AM - RTT News

Pre-Market Most Active for Jun 5, 2014 : RAD, S, RCAP, AUY, ALU, CIEN, QQQ, XIV, HALO, FB, ZNGA, MRVL
6/5/2014 8:39:56 AM - NASDAQ.com News

Sector Update: Technology Shares Flat Pre-Market; Clovis Oncology Upgraded to Buy at Stifel Nicolaus
6/5/2014 8:29:35 AM - MT Newswires

Sector Update: Healthcare Healthcare
6/5/2014 8:28:19 AM - MT Newswires

U.S. Hot Stocks: Hot Stocks to Watch
6/5/2014 8:18:00 AM - Dow Jones Business News

HALO Brightens, CPXX Eyes Long Haul, LJPC Awaits Next Catalyst
6/5/2014 1:03:00 AM - RTT News

Halozyme To Resume Trial In Pancreatic Cancer Drug; Stock Up - Update
6/4/2014 7:51:00 PM - RTT News

Halozyme to Resume Pancreatic Cancer Clinical Trial
6/4/2014 5:35:00 PM - Dow Jones Business News

After Hours Most Active for Jun 4, 2014 : WY, ALLY, WFM, FRX, XOM, RF, PL, INTC, CMCSA, MSFT, QQQ, HALO
6/4/2014 4:39:04 PM - NASDAQ.com News

Halozyme Therapeutics, Inc. (HALO) in Focus: Stock Up 6.9% - Tale of the Tape
5/14/2014 8:44:00 AM - Zacks.com

Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down
5/13/2014 3:44:07 PM - Benzinga

Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip
5/13/2014 12:40:01 PM - Benzinga